Skip to content
1887

Abstract

Mumps virus (MuV) is a negative-sense, single-stranded RNA virus belonging to the family . MuV causes acute infection of the parotid glands, and the infection can result in severe cases of encephalitis, meningitis and deafness in humans. The non-segmented RNA genome of MuV is encapsidated by the nucleocapsid protein (NP), which forms the ribonucleoprotein (RNP) complex that serves as a template for viral RNA synthesis. To make viral genomic RNA accessible to the viral polymerase, a conformational change within NP occurs. Recently, an atomic model of the NP of MuV was developed with cryogenic-electron microscopy (cryo-EM) using PIV5 NP crystal structure as a homology template. To examine NP’s structure and function, we performed mutational analysis of MuV NP at region(s) proposed to play a role in accessing viral RNA. The MuV NP mutants containing G185P, A197Q, Q200R and groups denoted as Top (N63G, P139D, A197Q), Tip (P109E, N121G, A124R) and Bottom (G21S, E29T, P43N, R93Q, R304Q) were first tested in a minigenome system. All mutations resulted in reduced reporter gene activities with Q200R and Bottom having the most severe negative effects. Rescuing of recombinant viruses with these mutations was attempted, and only MuV mutants ‘185 (G185P)’, ‘197 (A197Q)’ and ‘Top (N63G, P139D, A197A)’ were obtained. The ‘Top’ MuV mutant exhibited normal growth kinetics at low multiplicities of infection (MOIs); however, at high MOIs, the virus had reduced peak litres than low MOIs. Further analysis indicates that production of defective interfering particles (DI particles or DIPs) was enhanced by the mutant virus, indicating that this region, a known alpha-helix hinge region, is important for full-length genome replication, suggesting that it plays a role in maintaining stability of viral RNA-dependent RNA-polymerase on RNP template during MuV viral RNA synthesis. Understanding the production of DI particles will lead to a better understanding of MuV pathogenesis, as well as its replication/transcription process.

Funding
This study was supported by the:
  • National institutes of Health (Award R01AI106307)
    • Principle Award Recipient: HeBiao
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.002085
2025-04-11
2025-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/106/4/jgv002085.html?itemId=/content/journal/jgv/10.1099/jgv.0.002085&mimeType=html&fmt=ahah

References

  1. Carbone KM WJ. Mumps virus. In Knipe DM HP. eds Fields Virology, 4th. edn New York: Lippincott Williams and Wilkins; 2001 pp 1382–1441
    [Google Scholar]
  2. Hamborsky J, Kroger A. Epidemiology and prevention of vaccine-preventable diseases, the pink book. In Public Health Foundation 2015
    [Google Scholar]
  3. White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM. Measles, mumps, and rubella. Clin Obstet Gynecol 2012; 55:550–559 [View Article] [PubMed]
    [Google Scholar]
  4. Werner CA. Mumps orchitis and testicular atrophy; occurrence. Ann Intern Med 1950; 32:1066–1074 [View Article] [PubMed]
    [Google Scholar]
  5. Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R Soc Med 2006; 99:573–575 [View Article] [PubMed]
    [Google Scholar]
  6. Mizushima N, Murakami Y. Deafness following mumps: the possible pathogenesis and incidence of deafness. Auris Nasus Larynx 1986; 13 Suppl 1:S55–7 [View Article] [PubMed]
    [Google Scholar]
  7. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L et al. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2012; 86:615–620 [View Article] [PubMed]
    [Google Scholar]
  8. McNabb SJ, Jajosky RA, Hall-Baker PA, Adams DA, Sharp P et al. Summary of notifiable diseases - united states, 2005. Centers for Disease Control and 516 Prevention (CDC) 2007; 5411–92
    [Google Scholar]
  9. Lamb RA KD. Paramyxoviridae: the viruses and their replication, 4th edn. Philidelphia: Lippincott Williams and Wilkins; 2001
  10. Ortín J, Martín-Benito J. The RNA synthesis machinery of negative-stranded RNA viruses. Virology 2015; 479–480:532–544 [View Article] [PubMed]
    [Google Scholar]
  11. Cox R, Pickar A, Qiu S, Tsao J, Rodenburg C et al. Structural studies on the authentic mumps virus nucleocapsid showing uncoiling by the phosphoprotein. Proc Natl Acad Sci USA 2014; 111:15208–15213 [View Article]
    [Google Scholar]
  12. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 2018; 46:W296–W303 [View Article] [PubMed]
    [Google Scholar]
  13. Pickar A, Elson A, Yang Y, Xu P, Luo M et al. Oligomerization of mumps virus phosphoprotein. J Virol 2015; 89:11002–11010 [View Article] [PubMed]
    [Google Scholar]
  14. Nayak D, Panda D, Das SC, Luo M, Pattnaik AK. Single-amino-acid alterations in a highly conserved central region of vesicular stomatitis virus N protein differentially affect the viral nucleocapsid template functions. J Virol 2009; 83:5525–5534 [View Article] [PubMed]
    [Google Scholar]
  15. Shan H, Su X, Li T, Qin Y, Zhang N et al. Structural plasticity of mumps virus nucleocapsids with cryo-EM structures. Commun Biol 2021; 4:833 [View Article] [PubMed]
    [Google Scholar]
  16. Severin C, Terrell JR, Zengel JR, Cox R, Plemper RK et al. Releasing the genomic RNA sequestered in the mumps virus nucleocapsid. J Virol 2016; 90:10113–10119 [View Article]
    [Google Scholar]
  17. Bertoni M, Kiefer F, Biasini M, Bordoli L, Schwede T. Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology. Sci Rep 2017; 7:10480 [View Article] [PubMed]
    [Google Scholar]
  18. Alayyoubi M, Leser GP, Kors CA, Lamb RA. Structure of the paramyxovirus parainfluenza virus 5 nucleoprotein-RNA complex. Proc Natl Acad Sci USA 2015; 112:E1792–9 [View Article] [PubMed]
    [Google Scholar]
  19. Zengel J, Pickar A, Xu P, Lin A, He B. Roles of posphorylation of the nucleocapsid protein of mumps virus in regulating viral RNA transcription and replication. J Virol 2015; 89:7338–7347 [View Article] [PubMed]
    [Google Scholar]
  20. Xu P, Luthra P, Li Z, Fuentes S, D’Andrea JA et al. The V protein of mumps virus plays a critical role in pathogenesis. J Virol 2012; 86:1768–1776 [View Article] [PubMed]
    [Google Scholar]
  21. Xu P, Li Z, Sun D, Lin Y, Wu J et al. Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology 2011; 417:126–136 [View Article] [PubMed]
    [Google Scholar]
  22. Pickar A, Xu P, Elson A, Li Z, Zengel J et al. Roles of serine and threonine residues of mumps virus P protein in viral transcription and replication. J Virol 2014; 88:4414–4422 [View Article] [PubMed]
    [Google Scholar]
  23. Applied Biosystems® Minor Variant Software v1.0 User Guide Carlsbad, CA: Life Technologies; 2016
    [Google Scholar]
  24. Applied Biosystems® Detection and Quantification of Sequence Variants from Sanger Sequencing Traces: Determination of Minor Alleles by Analyzing Peak Height Data Life Technologies Corporation; 2013
    [Google Scholar]
  25. Roy S, Schreiber E. Detecting and quantifying low level gene variants in sanger sequencing traces using the ab1 peak reporter tool. J Biomol Tech 2014; 25:S13–S14
    [Google Scholar]
  26. Pickar A, Zengel J, Xu P, Li Z, He B. Mumps virus nucleoprotein enhances phosphorylation of the phosphoprotein by polo-like kinase 1. J Virol 2016; 90:1588–1598 [View Article] [PubMed]
    [Google Scholar]
  27. Modrego A, Carlero D, Arranz R, Martín-Benito J. CryoEM of viral ribonucleoproteins and nucleocapsids of single-stranded RNA viruses. Viruses 2023; 15:653 [View Article] [PubMed]
    [Google Scholar]
  28. Cox R, Green TJ, Qiu S, Kang J, Tsao J et al. Characterization of a mumps virus nucleocapsidlike particle. J Virol 2009; 83:11402–11406 [View Article] [PubMed]
    [Google Scholar]
  29. McCarthy M, Lazzarini RA. Intracellular nucleocapsid RNA of mumps virus. J Gen Virol 1982; 58 Pt 1:205–209 [View Article] [PubMed]
    [Google Scholar]
  30. Kingston RL, Baase WA, Gay LS. Characterization of nucleocapsid binding by the measles virus and mumps virus phosphoproteins. J Virol 2004; 78:8630–8640 [View Article] [PubMed]
    [Google Scholar]
  31. Kingston RL, Gay LS, Baase WS, Matthews BW. Structure of the nucleocapsid-binding domain from the mumps virus polymerase; an example of protein folding induced by crystallization. J Mol Biol 2008; 379:719–731 [View Article] [PubMed]
    [Google Scholar]
  32. Yang Y, Lyu T, Zhou R, He X, Ye K et al. The antiviral and antitumor effects of defective interfering particles/genomes and their mechanisms. Front Microbiol 2019; 10:1852 [View Article]
    [Google Scholar]
  33. Mura M, Combredet C, Najburg V, Sanchez David RY, Tangy F et al. Nonencapsidated 5’ copy-back defective interfering genomes produced by recombinant measles viruses are recognized by RIG-I and LGP2 but not MDA5. J Virol 2017; 91:10–128 [View Article] [PubMed]
    [Google Scholar]
  34. Killip MJ, Young DF, Gatherer D, Ross CS, Short JAL et al. Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction. J Virol 2013; 87:4798–4807 [View Article] [PubMed]
    [Google Scholar]
  35. Lazzarini RA, Keene JD, Schubert M. The origins of defective interfering particles of the negative-strand RNA viruses. Cell 1981; 26:145–154 [View Article] [PubMed]
    [Google Scholar]
  36. Re GG. Deletion mutants of paramyxoviruses. In The Paramyxoviruses Boston, MA: Springer US; 1991 pp 275–298 [View Article]
    [Google Scholar]
  37. Holland JJ, Doyle M. Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus. Infect Immun 1973; 7:526–531 [View Article] [PubMed]
    [Google Scholar]
  38. Andzhaparidze OG, Boriskin Yu S, Bogomolova NN, Drynov ID. Mumps virus-persistently infected cell cultures release defective interfering virus particles. J Gen Virol 1982; 63:499–503 [View Article] [PubMed]
    [Google Scholar]
  39. Xu J, Sun Y, Li Y, Ruthel G, Weiss SR et al. Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence. Nat Commun 2017; 8:799 [View Article]
    [Google Scholar]
  40. Yount JS, Gitlin L, Moran TM, López CB. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. J Immunol 2008; 180:4910–4918 [View Article] [PubMed]
    [Google Scholar]
  41. Childs K, Stock N, Ross C, Andrejeva J, Hilton L et al. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 2007; 359:190–200 [View Article] [PubMed]
    [Google Scholar]
  42. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004; 101:17264–17269 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jgv/10.1099/jgv.0.002085
Loading
/content/journal/jgv/10.1099/jgv.0.002085
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error